| abstract |
This invention relates to recombinant vectors expressing one or more of the human CMV (HCMV) glycoproteins US2, US3, US6 and US 11 or corresponding functional rhesus CMV (RhCMV) homologues Rhl82, Rhl84, Rhl85 or Rhl89, methods of making them, uses for them, expression products from them, and uses for the expression products. This invention also relates to recombinant cytomegalovirus vectors lacking one or more of the glycoproteins, methods of making them, uses for them, expression products from them, and uses for the expression products. |